Systematic identification of disease-causing promoter and untranslated region variants in 8040 undiagnosed individuals with rare disease

Whilst screening promoters and UTRs can uncover additional diagnoses for individuals with rare disease, including these regions in diagnostic pipelines is not likely to dramatically increase diagnostic yield. Nevertheless, we provide a framework to aid identification of these variants.

Authors

Institutions

Publication Details

Journal
Genome Medicine
Published
2025-04-14
DOI
https://doi.org/10.1186/s13073-025-01464-2
Citations
4
Primary Topic
Genomics and Rare Diseases
Type
article
Field-Weighted Citation Impact
7.27

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Systematic identification of disease-causing promoter and untranslated region variants in 8040 undiagnosed individuals with rare disease

Ruebena Dawes, Susan Walker, Jenny Lord, Elston N. D’Souza et al.
4 citations
Genome Medicine
Genomics and Rare Diseases
7.27
article

Systematic identification of disease-causing promoter and untranslated region variants in 8040 undiagnosed individuals with rare disease

Ruebena Dawes, Susan Walker, Jenny Lord, Elston N. D’Souza, Toby Candler, Alexander J. M. Blakes, Christopher B. Burge, Helen V. Firth, Stephan Sanders, Siddharth Banka, Jamie M. Ellingford, Sarah K. Hilton, Nayana Lahiri, Nicola Whiffin, Alexandra C Martin-Geary, Shan Dong, Emily E. Anderson, Nechama Wieder, Jonathan Talbot-Martin, Scott D. Findlay, Diana Baralle, Christopher Campbell, Maria Fernandes, Christian G E L DeGoede, Sarah Jenkinson
article en
4 citations

Abstract

Whilst screening promoters and UTRs can uncover additional diagnoses for individuals with rare disease, including these regions in diagnostic pipelines is not likely to dramatically increase diagnostic yield. Nevertheless, we provide a framework to aid identification of these variants.

Genome MedicineVol. 17(1)
Manchester Metropolitan University (GB), Lancashire Teaching Hospitals NHS Foundation Trust (GB), Centre for Human Genetics (GB), University of Liverpool (GB), University of California, San Francisco (US), University of Cambridge (GB), Manchester Academic Health Science Centre (GB), Bristol Royal Hospital for Children (GB), Cambridge University Hospitals NHS Foundation Trust (GB), Wellcome Sanger Institute (GB), Open Data Institute (GB), University of Manchester (GB), University of Oxford (GB), Manchester University NHS Foundation Trust (GB), Liverpool Women's Hospital (GB), NIHR Bristol Biomedical Research Centre (GB), Genomics England (GB), New York Genome Center (US), University of Southampton (GB), Massachusetts Institute of Technology (US), East Lancashire Hospitals NHS Trust (GB)
National Institute for Health and Care Research, Department of Health and Social Care, Manchester Biomedical Research Centre
Openalex Percentile: Top 3%
Genomics and Rare Diseases
7.27
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.